AltStreet
SEC filing record
Primary Source · SEC.gov

GLACIER BASIN BIOTECH FUND LLC

Fund Vehicle2023 vintage506(b), 3(c)(1)

Raised

Pre-open

Investors

—

Min Invest

$50,000

Is this your company or fund? Claim this page free.

Claim free

AltStreet Analysis

·

Generated from EDGAR primary sources

Glacier Basin Biotech Fund LLC is a Delaware pooled investment fund filed October 19, 2023, by executive officer Matthew McLoughlin under Rule 506(b) and Section 3(c)(1). The filing indicates pre-open status with no capital raised or investor count disclosed; minimum investment is set at $50,000. The fund targets longevity biotech investments and appears to operate independently without identified parent platforms or related entities.

This longevity biotech fund employs the standard 506(b) private placement exemption combined with 3(c)(1) status, consistent with the majority of private biotech investment vehicles. The $50,000 minimum investment threshold positions it at the retail-accessible end of the spectrum for specialized biotech funds, which typically range from $25K for emerging managers to $1M+ for established institutional platforms.

Data Flags

generalPre-open filing with no disclosed first sale date for a sub-$100M offering
related_entitiesNo related EDGAR entities found despite platform-style naming convention suggesting potential for multiple vehicles
states_of_solicitationStates of solicitation not specified on 506(b) filing, which typically requires state-by-state disclosure

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001997850
Entity NameGLACIER BASIN BIOTECH FUND LLC
ExemptionRule 506(b), Section 3(c), Section 3(c)(1)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(1) of the Investment Company Act: the fund is excluded from investment-company registration because it has no more than 100 beneficial owners.
Entity TypeLimited Liability Company
Jurisdiction of OrganizationDelaware
Issuer Address16903 199th Pl Ne, Woodinville, WA 98077
Phone(781) 789-5593
Industry / Fund TypePooled Investment Fund · Hedge Fund
Investment Company ActExcluded under Section 3(c)(1) (100 beneficial owners or fewer)
Securities TypePooled Investment Fund
First Sale DateNot yet occurred (as filed)
Filing DateOctober 19, 2023
Accession Number0001997850-23-000001
Total Offering AmountIndefinite
Total Amount Sold$0 (no sales yet)
Total Investors0 (no sales yet)
Non-Accredited InvestorsNone
Minimum Investment$50,000
Offering DurationIntended to last more than one year
Net Asset Value RangeDecline to Disclose
State (Issuer Address)WA
Amendment CountOriginal filing only

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

DOctober 19, 2023

In the Terminal

Filing events

0

none on file

Critical / warning

0 / 0

0 watch · 0 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

pre_sale

Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

MATTHEW MCLOUGHLIN

Executive Officer · WOODINVILLE, WA

Questions About GLACIER BASIN BIOTECH FUND LLC

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is GLACIER BASIN BIOTECH FUND LLC?

GLACIER BASIN BIOTECH FUND LLC is a Delaware limited liability company that filed a Form D with the SEC on October 19, 2023 as a hedge fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests. AltStreet links the issuer to GLACIER BASIN BIOTECH FUND LLC.

Is GLACIER BASIN BIOTECH FUND LLC legit?

AltStreet does not rate legitimacy; it reports the public record. GLACIER BASIN BIOTECH FUND LLC filed a Form D with the SEC on October 19, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. No sales had been reported as of that notice. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. The issuer is linked to GLACIER BASIN BIOTECH FUND LLC, which AltStreet has reviewed. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is GLACIER BASIN BIOTECH FUND LLC registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that GLACIER BASIN BIOTECH FUND LLC claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has GLACIER BASIN BIOTECH FUND LLC raised?

GLACIER BASIN BIOTECH FUND LLC reported that the first sale had not yet occurred as of the Form D filed October 19, 2023, so no amount sold or investor count is on file. The total offering amount is listed as indefinite.

Who can invest in GLACIER BASIN BIOTECH FUND LLC?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $50,000.

What is the minimum investment in GLACIER BASIN BIOTECH FUND LLC?

The Form D lists $50,000 as the minimum investment accepted from any outside investor as of October 19, 2023. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling GLACIER BASIN BIOTECH FUND LLC and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.

Who is behind GLACIER BASIN BIOTECH FUND LLC?

The Form D lists 1 related person: MATTHEW MCLOUGHLIN, executive officer. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is GLACIER BASIN BIOTECH FUND LLC located?

The issuer's address on its SEC filings is 16903 199th Pl Ne, Woodinville, WA 98077. Its phone number of record is (781) 789-5593. It is organized under the laws of Delaware.

How long is the GLACIER BASIN BIOTECH FUND LLC offering open?

The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

How large is GLACIER BASIN BIOTECH FUND LLC?

The issuer declined to disclose its net asset value range on the Form D, which the form permits.

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Platform verification: the separate analyst-reviewed program for platforms, with right of reply and a document library.

Claim this profile, freeVerify this entity, $480/yrPlatform verification, from $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.